VOREND voriconazole 200mg tablet blister pack

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

voriconazole, Quantity: 200 mg

Beschikbaar vanaf:

Medis Pharma Pty Ltd

INN (Algemene Internationale Benaming):

Voriconazole

farmaceutische vorm:

Tablet, film coated

Samenstelling:

Excipient Ingredients: croscarmellose sodium; povidone; microcrystalline cellulose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; triacetin; macrogol 3350

Toedieningsweg:

Oral

Eenheden in pakket:

28, 10, 56, 2, 14, 100, 50, 30, 20

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

Vorend is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Product samenvatting:

Visual Identification: white, oval biconvex tablets, debossed 'VC200' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2015-02-02